Alpha Tau Medical Ltd. announced that the Israeli Ministry of Environmental Protection has granted the Company an amended radioactive license in the main manufacturing floor of its production facility in Jerusalem, increasing the maximum allowable amount of Thorium-228 for use and possession to produce Alpha DaRT sources from 30 milliCurie to 100 milliCurie. This expanded license could support the production of up to 300,000 Alpha DaRT sources per year in this facility. In addition, the Company is also pleased to announce that it has received approvals from both the Israeli Ministry of Environmental Protection and the Animal Testing Council at the Israeli Ministry of Health for its pre-clinical radioactive laboratory at its Jerusalem headquarters, to conduct pre-clinical experiments utilizing mice and rats.

The Company has now successfully completed all requirements for the certification of this laboratory and may begin submitting experimental protocols for ethics committee approval.